Data through FY2026 Q3 (Jun 30, 2026)
Glenmark Pharmaceuticals, Inc. USA
Company profile for Glenmark Pharmaceuticals, Inc. USA covers 17 filings across the reporting window. FY2026 certified median offer: $126,644.
- FY2026 certified median
- $126,644
- Total filings
- 17
- FY2026 25th–75th percentile
- $108,524–$158,692
- Top job title
- Senior Director “ Quality, North America
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 4 | $115,880 | $106,319 | $126,250 |
| FY2025 | 9 | $139,616 | $117,360 | $196,286 |
| FY2026 (Q1–Q3) | 4 | $126,644 | $108,524 | $158,692 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Senior Director “ Quality, North America3 filings
- Manufacturing, Science & Technology (MSAT) Manager2 filings
- Validation Specialist2 filings
- Associate Manager, Demand Planning1 filings
- DIRECTOR ENGINEERING & PROJECTS1 filings
- Director of Quality Assurance1 filings
- Senior Manager- QC Stability1 filings
- Senior MSAT Specialist1 filings
- Senior Research Scientist1 filings
- Senior Validation Specialist1 filings
Top cities
- Monroe12 filings
- Elmwood Park4 filings
- Mahwah1 filings